Eliprodil
Eliprodil
Eliprodil is a pharmaceutical compound that acts as a non-competitive antagonist at the NMDA receptor, specifically targeting the NR2B subunit. It has been studied for its potential neuroprotective effects and its role in modulating glutamatergic neurotransmission.
Mechanism of Action
Eliprodil functions by inhibiting the activity of the NMDA receptor, a type of ionotropic glutamate receptor that plays a crucial role in synaptic plasticity and memory. By selectively binding to the NR2B subunit, Eliprodil reduces the influx of calcium ions into the neuron, which can help prevent excitotoxicity, a process that can lead to neuronal damage and cell death.
Pharmacological Effects
The primary pharmacological effect of Eliprodil is its neuroprotective capability. By modulating NMDA receptor activity, Eliprodil has been shown to reduce neuronal injury in various models of neurological disorders, including stroke and traumatic brain injury.
Clinical Applications
Although Eliprodil has demonstrated potential in preclinical studies, its clinical applications are still under investigation. Research has focused on its use in conditions such as ischemic stroke, where reducing excitotoxic damage could improve outcomes. However, further studies are needed to fully establish its efficacy and safety in humans.
Side Effects and Safety
As with many NMDA receptor antagonists, Eliprodil may have side effects related to its action on the central nervous system. These can include dizziness, nausea, and potential cognitive impairment. The safety profile of Eliprodil is still being evaluated in clinical trials.
Research and Development
Research into Eliprodil continues, with ongoing studies exploring its potential benefits and mechanisms of action. The compound's ability to selectively target the NR2B subunit makes it a promising candidate for further development in the treatment of neurodegenerative diseases.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
